Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 47% ± 14% | |
lung | 17 studies | 44% ± 18% | |
intestine | 13 studies | 28% ± 15% | |
kidney | 9 studies | 40% ± 13% | |
liver | 6 studies | 35% ± 12% | |
pancreas | 5 studies | 39% ± 18% | |
bone marrow | 5 studies | 36% ± 12% | |
placenta | 4 studies | 56% ± 26% | |
prostate | 4 studies | 31% ± 11% | |
lymph node | 4 studies | 45% ± 25% | |
breast | 4 studies | 34% ± 8% | |
uterus | 3 studies | 44% ± 10% | |
thymus | 3 studies | 52% ± 29% | |
brain | 3 studies | 39% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3762.43 | 653 / 653 | 100% | 588.90 | 604 / 605 |
kidney | 100% | 6492.73 | 89 / 89 | 100% | 433.02 | 897 / 901 |
lung | 100% | 5957.38 | 577 / 578 | 99% | 553.79 | 1145 / 1155 |
pancreas | 100% | 3079.41 | 328 / 328 | 98% | 479.88 | 175 / 178 |
liver | 100% | 2765.53 | 226 / 226 | 97% | 295.59 | 392 / 406 |
prostate | 97% | 3146.18 | 237 / 245 | 99% | 351.70 | 495 / 502 |
breast | 95% | 2370.32 | 438 / 459 | 99% | 528.65 | 1109 / 1118 |
stomach | 87% | 3034.01 | 311 / 359 | 98% | 302.81 | 281 / 286 |
bladder | 76% | 1774.62 | 16 / 21 | 98% | 556.18 | 493 / 504 |
intestine | 68% | 2594.59 | 658 / 966 | 99% | 366.11 | 522 / 527 |
esophagus | 60% | 3171.83 | 869 / 1445 | 100% | 264.94 | 183 / 183 |
skin | 72% | 3976.49 | 1305 / 1809 | 73% | 178.53 | 345 / 472 |
uterus | 21% | 260.58 | 36 / 170 | 93% | 512.07 | 425 / 459 |
ovary | 8% | 74.74 | 15 / 180 | 100% | 410.98 | 428 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 822.15 | 29 / 29 |
spleen | 100% | 5200.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 454.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 394.00 | 1 / 1 |
peripheral blood | 98% | 2979.58 | 910 / 929 | 0% | 0 | 0 / 0 |
adipose | 92% | 1562.66 | 1108 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 76% | 859.01 | 196 / 258 | 9% | 21.11 | 21 / 230 |
brain | 10% | 100.05 | 272 / 2642 | 39% | 67.91 | 277 / 705 |
eye | 0% | 0 | 0 / 0 | 41% | 76.49 | 33 / 80 |
blood vessel | 37% | 492.89 | 492 / 1335 | 0% | 0 | 0 / 0 |
heart | 19% | 191.69 | 166 / 861 | 0% | 0 | 0 / 0 |
muscle | 7% | 54.08 | 55 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043308 | Biological process | eosinophil degranulation |
GO_0051607 | Biological process | defense response to virus |
GO_1903531 | Biological process | negative regulation of secretion by cell |
GO_0035493 | Biological process | SNARE complex assembly |
GO_0016240 | Biological process | autophagosome membrane docking |
GO_1903595 | Biological process | positive regulation of histamine secretion by mast cell |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0043312 | Biological process | neutrophil degranulation |
GO_0015031 | Biological process | protein transport |
GO_0006906 | Biological process | vesicle fusion |
GO_1903076 | Biological process | regulation of protein localization to plasma membrane |
GO_0070254 | Biological process | mucus secretion |
GO_0097352 | Biological process | autophagosome maturation |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0031902 | Cellular component | late endosome membrane |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0005769 | Cellular component | early endosome |
GO_0031901 | Cellular component | early endosome membrane |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
GO_0005829 | Cellular component | cytosol |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0098594 | Cellular component | mucin granule |
GO_0042589 | Cellular component | zymogen granule membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0031982 | Cellular component | vesicle |
GO_0031201 | Cellular component | SNARE complex |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0019905 | Molecular function | syntaxin binding |
GO_0005484 | Molecular function | SNAP receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0019869 | Molecular function | chloride channel inhibitor activity |
Gene name | VAMP8 |
Protein name | Vesicle-associated membrane protein 8 (Endobrevin) Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (EDB) |
Synonyms | |
Description | FUNCTION: SNAREs, soluble N-ethylmaleimide-sensitive factor-attachment protein receptors, are essential proteins for fusion of cellular membranes. SNAREs localized on opposing membranes assemble to form a trans-SNARE complex, an extended, parallel four alpha-helical bundle that drives membrane fusion. VAMP8 is a SNARE involved in autophagy through the direct control of autophagosome membrane fusion with the lysososome membrane via its interaction with the STX17-SNAP29 binary t-SNARE complex . Also required for dense-granule secretion in platelets . Also plays a role in regulated enzyme secretion in pancreatic acinar cells (By similarity). Involved in the abscission of the midbody during cell division, which leads to completely separate daughter cells (By similarity). Involved in the homotypic fusion of early and late endosomes (By similarity). Participates also in the activation of type I interferon antiviral response through a TRIM6-dependent mechanism . . |
Accessions | Q9BV40 ENST00000432071.1 ENST00000409760.1 B8ZZT4 ENST00000263864.10 C9JXZ5 |